The FDA has granted orphan drug designation to rilzabrutinib for IgG4-related disease and warm autoimmune hemolytic anemia, ...
History of drug-induced immune thrombocytopenia with use ... Not for group A β-hemolytic strep. Avoid prolonged administration. Monitor CBCs, urine, and renal function. Hepatic or renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback